Reporter Sept 24 2021

Evan Campa and Eben Cathey, along with their children, Mae and Reuben, are helping to raise funds to create an ALS research program at VUMC.

Local family shines in campaign to establish ALS research program

Sep. 23, 2021—Evan Campa and her family are at the forefront of a campaign to establish an ALS basic science research program at Vanderbilt.

Scott Zuckerman, MD, MPH, left, Aaron Yengo-Kahn, MD, and colleagues are studying sports-related concussion recovery patterns in young Black and white athletes.

Study explores concussion recovery by race

Sep. 23, 2021—Vanderbilt researchers are exploring the outcomes and experiences of Black and White athletes following a sports-related concussion.

The team studying smell and taste loss associated with COVID-19 includes, from left, Rakesh Chandra, MD, Justin Turner, MD, Timothy Trone, MD, and Nikita Chapurin, MD, MHS.

Study tracks smell, taste loss associated with COVID

Sep. 23, 2021—Vanderbilt researchers are studying ways to better evaluate and predict who is at risk of persistent smell and taste loss after COVID-19 infection.

As part of International Housekeepers & Environmental Services Week, VUMC honored workers like Lakeshia Fletcher, shown here wiping down tables in the Café at Monroe Carell Jr. Children’s Hospital at Vanderbilt, who have been on the front lines during the pandemic to keep facilities clean and safe.

Clean and safe

Sep. 23, 2021—VUMC recently honored workers who have been on the front lines during the pandemic to keep facilities clean and safe.

Steven Webber, MBChB, MRCP, delivered last week’s State of the Department of Pediatrics address at Monroe Carell Jr. Children’s Hospital at Vanderbilt.

People key to Pediatrics’ many successes: Webber

Sep. 23, 2021—Vanderbilt's State of the Department of Pediatrics address highlighted the successes of the past year, recapped the ongoing challenges of the COVID-19 pandemic and described the road ahead.

Clinical trial tests ATR inhibitor in difficult-to-treat cancers

Sep. 23, 2021— by Tom Wilemon A clinical trial has been launched to test a new targeted therapy in patients with advanced and difficult-to-treat cancers. Satya Das, MD, MSCI, assistant professor of Medicine at Vanderbilt-Ingram Cancer Center (VICC), is the national principal investigator for the trial (NCT04514497) that is now enrolling people with metastatic small cell lung...

Janna Landsperger, MSN, RN, ACNP, seated, helps conduct the ACNP/PA Critical Care Boot Camp from a conference room in Medical Center North. Presenting on screen is Allison Wynes, a nurse practitioner at University of Iowa Hospitals and Clinics.

‘Boot Camp’ helps sharpen critical care skills

Sep. 23, 2021—About 250 nurse practitioners and physician associates nationwide gathered over Zoom recently for Vanderbilt's annual ACNP/PA Critical Care Boot Camp.

Lynne Warner Stevenson, MD, has been honored for her contributions to the field of heart failure.

Stevenson receives HFSA Lifetime Achievement Award

Sep. 23, 2021—Vanderbilt's Lynne Warner Stevenson, MD, has received the Lifetime Achievement Award from the Heart Failure Society of America.

Eng named co-chair of NCI clinical trials steering committee

Sep. 23, 2021—Vanderbilt's Cathy Eng, MD, has been elected co-chair of the National Cancer Institute (NCI) Gastrointestinal Cancer Steering Committee.

Rounds: Hard conversations

Sep. 22, 2021—Difficult conversations are a hallmark of medicine. Patients and their families rely on us to share the facts about their illnesses that are sometimes hard to hear. While many clinicians begin to do this while training, our effectiveness in these conversations develops throughout a career. Telling a young mother she has an aggressive cancer or...

Kannankeril named inaugural holder of the Richard B. Johnston Jr., MD, Chair in Pediatric Research

Sep. 22, 2021—Prince Kannankeril, MD, MSCI, has been appointed inaugural holder of the Richard B. Johnston Jr. MD, Chair in Pediatric Research at Vanderbilt University Medical Center.

“Ultra-potent” antibody against COVID-19 variants isolated at VUMC

Sep. 22, 2021—A technology developed at Vanderbilt has led to the discovery of an “ultra-potent” monoclonal antibody against multiple variants of SARS-CoV-2, the virus responsible for COVID-19, including the delta variant.